These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience. Karol D; McKinnon M; Mukhtar L; Awan A; Lo B; Wheatley-Price P Front Oncol; 2021; 11():687730. PubMed ID: 34381713 [TBL] [Abstract][Full Text] [Related]
5. A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Takajo T; Kirishima M; Hamada T; Matsuo K; Fujio S; Hanada T; Hosoyama H; Yonenaga M; Sakamoto A; Hiraki T; Tanimoto A; Yoshimoto K Cancer Sci; 2020 Oct; 111(10):3902-3911. PubMed ID: 32748499 [TBL] [Abstract][Full Text] [Related]
6. Clinical Impact of Next-generation Sequencing in Pediatric Neuro-Oncology Patients: A Single-institutional Experience. Barsan V; Paul M; Gorsi H; Malicki D; Elster J; Kuo DJ; Crawford J Cureus; 2019 Dec; 11(12):e6281. PubMed ID: 31827999 [TBL] [Abstract][Full Text] [Related]
7. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927 [TBL] [Abstract][Full Text] [Related]
8. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients. Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864 [TBL] [Abstract][Full Text] [Related]
9. Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel. Zacher A; Kaulich K; Stepanow S; Wolter M; Köhrer K; Felsberg J; Malzkorn B; Reifenberger G Brain Pathol; 2017 Mar; 27(2):146-159. PubMed ID: 26919320 [TBL] [Abstract][Full Text] [Related]
10. Next generation sequencing of glioblastoma circulating tumor cells: non-invasive solution for disease monitoring. Kolostova K; Pospisilova E; Pavlickova V; Bartos R; Sames M; Pawlak I; Bobek V Am J Transl Res; 2021; 13(5):4489-4499. PubMed ID: 34150029 [TBL] [Abstract][Full Text] [Related]
11. TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations. Arita H; Matsushita Y; Machida R; Yamasaki K; Hata N; Ohno M; Yamaguchi S; Sasayama T; Tanaka S; Higuchi F; Iuchi T; Saito K; Kanamori M; Matsuda KI; Miyake Y; Tamura K; Tamai S; Nakamura T; Uda T; Okita Y; Fukai J; Sakamoto D; Hattori Y; Pareira ES; Hatae R; Ishi Y; Miyakita Y; Tanaka K; Takayanagi S; Otani R; Sakaida T; Kobayashi K; Saito R; Kurozumi K; Shofuda T; Nonaka M; Suzuki H; Shibuya M; Komori T; Sasaki H; Mizoguchi M; Kishima H; Nakada M; Sonoda Y; Tominaga T; Nagane M; Nishikawa R; Kanemura Y; Kuchiba A; Narita Y; Ichimura K Acta Neuropathol Commun; 2020 Nov; 8(1):201. PubMed ID: 33228806 [TBL] [Abstract][Full Text] [Related]
12. Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats. Movassaghi M; Shabihkhani M; Hojat SA; Williams RR; Chung LK; Im K; Lucey GM; Wei B; Mareninov S; Wang MW; Ng DW; Tashjian RS; Magaki S; Perez-Rosendahl M; Yang I; Khanlou N; Vinters HV; Liau LM; Nghiemphu PL; Lai A; Cloughesy TF; Yong WH Exp Mol Pathol; 2017 Aug; 103(1):87-93. PubMed ID: 28663030 [TBL] [Abstract][Full Text] [Related]
13. Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel. Romanidou O; Apostolou P; Kouvelakis K; Tsangaras K; Eliades A; Achilleos A; Loizides C; Lemesios C; Ioannides M; Kypri E; Koumbaris G; Papadopoulou K; Papathanasiou A; Rigakos G; Xanthakis I; Fostira F; Kotoula V; Fountzilas G; Patsalis PC Oncol Lett; 2023 Jan; 25(1):38. PubMed ID: 36589665 [TBL] [Abstract][Full Text] [Related]
14. Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing. Al Zoughbi W; Fox J; Beg S; Papp E; Hissong E; Ohara K; Keefer L; Sigouros M; Kane T; Bockelman D; Nichol D; Patchell E; Bareja R; Karandikar A; Alnajar H; Cerqueira G; Guthrie VB; Verner E; Manohar J; Greco N; Wilkes D; Tagawa S; Malbari MS; Holcomb K; Eng KW; Shah M; Altorki NK; Sboner A; Nanus D; Faltas B; Sternberg CN; Simmons J; Houvras Y; Molina AM; Angiuoli S; Elemento O; Mosquera JM Oncologist; 2021 Nov; 26(11):e1971-e1981. PubMed ID: 34286887 [TBL] [Abstract][Full Text] [Related]
15. Practice of the New Integrated Molecular Diagnostics in Gliomas: Experiences and New Findings in a Single Chinese Center. Hu WM; Wang F; Xi SY; Zhang X; Lai JP; Wu HY; Liu LL; Sai K; Zeng J J Cancer; 2020; 11(6):1371-1382. PubMed ID: 32047544 [No Abstract] [Full Text] [Related]
16. LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated Macrophages. Hu WM; Yang YZ; Zhang TZ; Qin CF; Li XN Front Med (Lausanne); 2020; 7():182. PubMed ID: 32528967 [No Abstract] [Full Text] [Related]
17. FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas. Sharaf R; Pavlick DC; Frampton GM; Cooper M; Jenkins J; Danziger N; Haberberger J; Alexander BM; Cloughesy T; Yong WH; Liau LM; Nghiemphu PL; Ji M; Lai A; Ramkissoon SH; Albacker LA Neurooncol Adv; 2021; 3(1):vdab017. PubMed ID: 33778493 [TBL] [Abstract][Full Text] [Related]
18. Molecular Profiling of Advanced Malignancies: A Community Oncology Network Experience and Review of Literature. Tayshetye P; Miller K; Monga D; Brem C; Silverman JF; Finley GG Front Med (Lausanne); 2020; 7():314. PubMed ID: 32760731 [No Abstract] [Full Text] [Related]
19. Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers. Figarella-Branger D; Maues de Paula A; Colin C; Bouvier C Rev Neurol (Paris); 2011 Oct; 167(10):683-90. PubMed ID: 21889777 [TBL] [Abstract][Full Text] [Related]
20. Genomic characterization of recurrent high-grade astroblastoma. Bale TA; Abedalthagafi M; Bi WL; Kang YJ; Merrill P; Dunn IF; Dubuc A; Charbonneau SK; Brown L; Ligon AH; Ramkissoon SH; Ligon KL Cancer Genet; 2016; 209(7-8):321-30. PubMed ID: 27425854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]